Exact Mass: 328.2777

Exact Mass Matches: 328.2777

Found 373 metabolites which its exact mass value is equals to given mass value 328.2777, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Stanozolol

1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-Trimethyl-cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol

C21H32N2O (328.2515)


Stanozolol is only found in individuals that have used or taken this drug. Stanozolol has is a synthetic anabolic steroid with therapeutic uses in treating hereditary angioedema. Stanozolol was first synthesized by Clinton et al. in 1959, as a heterocyclic anabolic androgenic steroid. The structure of Stanozolol differs from endogenous steroid hormones and most commercially available anabolic steroids. It most closely resembles methyl testosterone. Instead of the 3-ketogroup in methyltestosterone, there is a pyrazole ring fused to the androstane ring system. This slightly different structure has the disadvantage of making extraction and isolation of the molecule from matrices more difficult. Like most other anabolic steroids, Stanozolol has poor gas chromatographic behavior and is difficult to detect in urine, because of renal clearance and low urinary excretion. This is due to the rapid metabolization, leading to low concentration levels of the parent compound found in urine. Therefore, most research studies had focused on the detection of urinary metabolites. Androgens are drugs, derived from the natural male sex hormone testosterone, with high anabolic potential and minimized androgenic activity. It has been abused by several high profile professional athletes. Stanozolol binds to androgen receptors, such as membrane bound receptor proteins LAGS and stanozolol-binding protein (STBP). Anabolic steroids stimulate protein synthesis, resulting in an acceleration of the food conversion rate and increasing muscle growth, body mass and enhanced performance. Androgens can be used as therapeutics, because they accelerate the recovery of protein deficiency and protein-wasting disorders (e.g. osteoporosis), but they are also widely abused in doping, as well in animals as in men. (PMID: 10404632, 10435307, 11175645, 11284331, 12064656, 12580506, 1448813, 14698206, 15013688, 15458725, 15631866, 15664350, 16040239, 16259046, 16288903, 1640693, 17066372, 17146762, 2306548, 2362445, 2625454, 2663904, 6539197, 9001957, 9300863, 9580049). Stanozolol was first synthesized by Clinton et al. in 1959, as a heterocyclic anabolic androgenic steroid. The structure of Stan differs from endogenous steroid hormones and most commercially available anabolic steroids. It most closely resembles methyl testosterone. Instead of the 3-ketogroup in methyltestosterone, there is a pyrazole ring fused to the androstane ring system. This slightly different structure has the disadvantage of making extraction and isolation of the molecule from matrices more difficult. Like most other anabolic steroids, Stan has poor gas chromatographic behavior and is difficult to detect in urine, because of renal clearance and low urinary excretion. This is due to the rapid metabolization, leading to low concentration levels of the parent compound found in urine. Therefore, most research studies had focused on the detection of urinary metabolites. A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   

Docosahexaenoic acid

(4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19-hexaenoic acid

C22H32O2 (328.2402)


Docosahexaenoic acid (DHA) is an omega-3 essential fatty acid. Chemically, DHA is a carboxylic acid with a 22-carbon chain and six cis- double bonds with the first double bond located at the third carbon from the omega end. DHA is most often found in fish oil. It is a major fatty acid in sperm and brain phospholipids, especially in the retina. Dietary DHA can reduce the level of blood triglycerides in humans, which may reduce the risk of heart disease (Wikipedia). Docosahexaenoic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism. Extensively marketed as a dietary supplement in Japan [DFC]. Doconexent is found in many foods, some of which are mung bean, fruit preserve, northern pike, and snapper. COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.

   

2-hydroxyphytanic acid

(2S)-2-hydroxy-3,7,11,15-tetramethylhexadecanoic acid

C20H40O3 (328.2977)


A methylated long-chain hyroxy fatty acid formed during alpha-oxidation of phytanic acid by liver mitochondria and peroxisomes, but it is detected in tissues only in patients with peroxisomal disorders.

   

NCIOpen2_008429

6alpha-Methylpregn-4-ene-3,20-dione

C22H32O2 (328.2402)


   

2alpha-Methylprogesterone

2alpha-Methylpregn-4-ene-3,20-dione; 2alpha-Methylprogesterone

C22H32O2 (328.2402)


   

16beta-Methylprogesterone

16beta-Methylpregn-4-ene-3,20-dione

C22H32O2 (328.2402)


   

7alpha-Methylprogesterone

7alpha-Methyl-4-pregnene-3,20-dione

C22H32O2 (328.2402)


   

Promestriene

Promestriene

C22H32O2 (328.2402)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03C - Estrogens > G03CA - Natural and semisynthetic estrogens, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Avocadene 4-acetate

1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613)


Avocadene 4-acetate is found in fruits. Avocadene 4-acetate is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Avocadene 4-acetate is found in fruits.

   

Avocadene 1-acetate

2,4-dihydroxyheptadec-16-en-1-yl acetate

C19H36O4 (328.2613)


Avocadene 1-acetate is found in fruits. Avocadene 1-acetate is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Avocadene 1-acetate is found in fruits.

   

3-hydroxyicosanoic Acid

beta-Hydroxyeicosanoic acid

C20H40O3 (328.2977)


3-hydroxyicosanoic Acid is also known as 3-Hydroxyeicosanoate or 3-Hydroxyarachidic acid. 3-hydroxyicosanoic Acid is considered to be practically insoluble (in water) and acidic. 3-hydroxyicosanoic Acid can be synthesized from arachidic acid. 3-hydroxyicosanoic Acid can be synthesized into 3-hydroxyicosanoyl-CoA. 3-hydroxyicosanoic Acid is a fatty acid lipid molecule

   

Grifolin

5-methyl-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,3-diol

C22H32O2 (328.2402)


Grifolin is found in mushrooms. Grifolin is isolated from the edible maitake mushroom (Grifola confluens Isolated from the edible maitake mushroom (Grifola confluens). Grifolin is found in mushrooms.

   

(Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol

2-methyl-5-[(8Z,11E)-pentadeca-8,11,14-trien-1-yl]benzene-1,3-diol

C22H32O2 (328.2402)


(Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol is found in nuts. (Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol is a constituent of cashew nut shell oil (Anacardium occidentale). Constituent of cashew nut shell oil (Anacardium occidentale). (Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol is found in nuts.

   

MG(16:1(9Z)/0:0/0:0)

(2S)-2,3-dihydroxypropyl (9Z)-hexadec-9-enoate

C19H36O4 (328.2613)


MG(16:1(9Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(16:1(9Z)/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(16:1(9Z)/0:0/0:0) is made up of one 9Z-hexadecenoyl(R1).

   

Neogrifolin

5-methyl-4-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,3-diol

C22H32O2 (328.2402)


Neogrifolin is found in mushrooms. Neogrifolin is a constituent of Albatrellus ovinus Constituent of Albatrellus ovinus. Neogrifolin is found in mushrooms.

   

Retinol acetate

(2E,4E,6Z)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetic acid

C22H32O2 (328.2402)


Retinol acetate is a dietary supplement, permitted in infant formula Dietary supplement, permitted in infant formulas Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities.

   

2(R)-hydroxyicosanoic acid

alpha-Hydroxyeicosanoic acid

C20H40O3 (328.2977)


2(R)-Hydroxyicosanoic acid is along-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.

   

MG(0:0/16:1(9Z)/0:0)

1,3-dihydroxypropan-2-yl (9Z)-hexadec-9-enoate

C19H36O4 (328.2613)


MG(0:0/16:1(9Z)/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(0:0/16:1(9Z)/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/16:1(9Z)/0:0) is made up of one 9Z-hexadecenoyl(R2).

   

Avocadene 2-acetate

1,4-dihydroxyheptadec-16-en-2-yl acetate

C19H36O4 (328.2613)


Avocadene 2-acetate is found in fruits. Avocadene 2-acetate is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Avocadene 2-acetate is found in fruits.

   

Polyoxyethylene 40 monostearate

17-Hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl octadecanoate

C20H40O3 (328.2977)


Polyoxyethylene 40 monostearate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials It is used as a food additive .

   

12-hydroxyicosanoic acid

12-hydroxyicosanoic acid

C20H40O3 (328.2977)


12-Hydroxyicosanoic acid is a long-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.

   

15-hydroxyicosanoic acid

15-Hydroxyeicosanoic acid, (S)-isomer

C20H40O3 (328.2977)


15-Hydroxyicosanoic acid is a long-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.

   

N-Lauroyl Glutamine

4-carbamoyl-2-dodecanamidobutanoic acid

C17H32N2O4 (328.2362)


N-lauroyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Lauroyl Lysine

6-amino-2-dodecanamidohexanoic acid

C18H36N2O3 (328.2726)


N-lauroyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Lysine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Glyceryl palmitoleate

2,3-Dihydroxypropyl hexadec-9-enoic acid

C19H36O4 (328.2613)


   

Docosahexaenoicacid(DHA)

DOCOSA-2,4,6,8,10,12-HEXAENOIC ACID

C22H32O2 (328.2402)


   

Methyl 8-[3-(2-hydroxyoctyl)oxiran-2-yl]octanoate

Methyl 8-[3-(2-hydroxyoctyl)oxiran-2-yl]octanoic acid

C19H36O4 (328.2613)


   

9-cis Retinol Acetate

3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetic acid

C22H32O2 (328.2402)


Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities.

   

(4E,7E,10Z,13E,16E,19E)-Docosa-4,7,10,13,16,19-hexaenoic acid

(4E,7E,10Z,13E,16E,19E)-Docosa-4,7,10,13,16,19-hexaenoic acid

C22H32O2 (328.2402)


   

Promestrienum

14-methoxy-15-methyl-5-propoxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene

C22H32O2 (328.2402)


   

FA 22:6

4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid

C22H32O2 (328.2402)


Chemical was purchased from CAY 90310 (Lot. 0458708-4); Diagnostic ions: 327.1, 283.2, 229.7,191.1, 177.2 COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials CONFIDENCE standard compound; INTERNAL_ID 296 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.

   

Uvarisesquiterpene A

Uvarisesquiterpene A

C22H32O2 (328.2402)


   

12,14-Dihydroxyphytol

(-)-12,14-Dihydroxyphytol

C20H40O3 (328.2977)


   

Uvarisesquiterpene C

1,2,3,3a,4,5,5a,6,11a,11b-Decahydro-3a,11a-dimethyl-a-(1-methylethyl)-cyclopenta[c]xanthene-1-methanol

C22H32O2 (328.2402)


   

Piperogalin

Piperogalin

C22H32O2 (328.2402)


   

Beilcyclone A

Beilcyclone A

C23H36O (328.2766)


   

Totaryl acetate

Totaryl acetate

C22H32O2 (328.2402)


   

20-Hydroxyeicosanoic acid

20-Hydroxyeicosanoic acid

C20H40O3 (328.2977)


   

Cervonic acid

DOCOSAHEXAENOIC ACID

C22H32O2 (328.2402)


Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.

   

Trimethylsilyl palmitoate

Hexadecanic acid, trimethylsilyl ester

C19H40O2Si (328.2797)


   

icos-19-ene-1,2,4-triol

icos-19-ene-1,2,4-triol

C20H40O3 (328.2977)


   

CHEMBL3637882

CHEMBL3637882

C18H28N6 (328.2375)


   

2,4-Dimethyl-6-(3-methyl-isobuten-5-isopropyl)-phenyl-3,5-hexanedione

2,4-Dimethyl-6-(3-methyl-isobuten-5-isopropyl)-phenyl-3,5-hexanedione

C22H32O2 (328.2402)


   

5-methyl-2-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]-1,4-benzenediol

5-methyl-2-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]-1,4-benzenediol

C22H32O2 (328.2402)


   

14,16-dinor-plakortide Q

14,16-dinor-plakortide Q

C19H36O4 (328.2613)


   
   

18-Acetoxyabieta-8,11,13-triene

18-Acetoxyabieta-8,11,13-triene

C22H32O2 (328.2402)


   

(5alpha)-4,4,8,10,14-pentamethylgon-12-ene-3,17-dione|cylindrictone F

(5alpha)-4,4,8,10,14-pentamethylgon-12-ene-3,17-dione|cylindrictone F

C22H32O2 (328.2402)


   

CYCLOSPONGIAQUINONE-1

CYCLOSPONGIAQUINONE-1

C22H32O2 (328.2402)


   

Norcon-5-enine, 3.beta.-(methylamino)-

Norcon-5-enine, 3.beta.-(methylamino)-

C22H36N2 (328.2878)


   

4-Ac-16-Heptadecene-1,2,4-triol

4-Ac-16-Heptadecene-1,2,4-triol

C19H36O4 (328.2613)


   

docosahexaenoic acid (DHA)

docosahexaenoic acid (DHA)

C22H32O2 (328.2402)


   

methyl 16-acetyloxyhexadecanoate

methyl 16-acetyloxyhexadecanoate

C19H36O4 (328.2613)


   

2alpha-Acetoxy-abietatriene

2alpha-Acetoxy-abietatriene

C22H32O2 (328.2402)


   

2Z-phytene-1,15,20-triol

2Z-phytene-1,15,20-triol

C20H40O3 (328.2977)


   

3alpha-Amino-conanen-(5)

3alpha-Amino-conanen-(5)

C22H36N2 (328.2878)


   

methyl-9-methoxy-stearate

methyl-9-methoxy-stearate

C20H40O3 (328.2977)


   

SCHEMBL6555168

SCHEMBL6555168

C20H40O3 (328.2977)


   

SCHEMBL18248655

SCHEMBL18248655

C19H36O4 (328.2613)


   

2-hydroxyoctadecyl acetate

2-hydroxyoctadecyl acetate

C20H40O3 (328.2977)


   

Methyl 2-(acetyloxy)hexadecanoate

Methyl 2-(acetyloxy)hexadecanoate

C19H36O4 (328.2613)


   

des-A-lup-9-ene

des-A-lup-9-ene

C24H40 (328.313)


   

1-(15-methylhexadec-1-enyloxy)-2,3-propanediol

1-(15-methylhexadec-1-enyloxy)-2,3-propanediol

C20H40O3 (328.2977)


   

4-Epidehydroabietol acetate

4-Epidehydroabietol acetate

C22H32O2 (328.2402)


   
   

Acetyl ferruginol

Acetyl ferruginol

C22H32O2 (328.2402)


   

11-n-octyltetracyclo[5,4,2,0(3,13)0(10,12)]trideca-4,8-dien-6-oic acid|beilschmiedic acid E

11-n-octyltetracyclo[5,4,2,0(3,13)0(10,12)]trideca-4,8-dien-6-oic acid|beilschmiedic acid E

C22H32O2 (328.2402)


   

11-n-octyltetracyclo[5,4,2,0(3,13)0(10,12)]trideca-5,8-dien-6-oic acid|beilschmiedic acid D

11-n-octyltetracyclo[5,4,2,0(3,13)0(10,12)]trideca-5,8-dien-6-oic acid|beilschmiedic acid D

C22H32O2 (328.2402)


   

2-Ac-16-Heptadecene-1,2,4-triol

2-Ac-16-Heptadecene-1,2,4-triol

C19H36O4 (328.2613)


   

4-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-5-methyl-2-(3-methylbut-2-enyl)benzene-1,3-diol

4-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-5-methyl-2-(3-methylbut-2-enyl)benzene-1,3-diol

C22H32O2 (328.2402)


   

topsendine B

topsendine B

C22H36N2 (328.2878)


   

woodylide B

woodylide B

C19H36O4 (328.2613)


   

(+)-4-hydroxy undecyl nonanoate

(+)-4-hydroxy undecyl nonanoate

C20H40O3 (328.2977)


   

3beta-acetoxy-abietatriene

3beta-acetoxy-abietatriene

C22H32O2 (328.2402)


   

19-nor,14alphaH-cheilantha-13(24),17-diene

19-nor,14alphaH-cheilantha-13(24),17-diene

C24H40 (328.313)


   
   

dasyscyphin D

dasyscyphin D

C22H32O2 (328.2402)


   

20-hydroxyicosanoic acid

20-hydroxyicosanoic acid

C20H40O3 (328.2977)


An omega-hydroxy fatty acid that is icosanoic acid (arachidonic acid) in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.

   

ethyl 3-hydroxyoctadecanoate

ethyl 3-hydroxyoctadecanoate

C20H40O3 (328.2977)


   

SCHEMBL18909010

SCHEMBL18909010

C22H32O2 (328.2402)


   

1-Ac-16-Heptadecene-1,2,4-triol

1-Ac-16-Heptadecene-1,2,4-triol

C19H36O4 (328.2613)


   

18-Hydroxyicosanoic acid

18-Hydroxyicosanoic acid

C20H40O3 (328.2977)


   

(+)-sempervirol acetate|Semipervirol-acetat|sempervirol acetate|Sempervirolacetat|semperviryl acetate|Semperviryl-acetat

(+)-sempervirol acetate|Semipervirol-acetat|sempervirol acetate|Sempervirolacetat|semperviryl acetate|Semperviryl-acetat

C22H32O2 (328.2402)


   

albatrellutin|[3R-(7,11-dimethylnona-6,10-dienyl)-3,7-dimethyl-chroman-1-ol]

albatrellutin|[3R-(7,11-dimethylnona-6,10-dienyl)-3,7-dimethyl-chroman-1-ol]

C22H32O2 (328.2402)


   

9,12-DIHYDROXYNONADEC-15-ENOIC ACID

9,12-DIHYDROXYNONADEC-15-ENOIC ACID

C19H36O4 (328.2613)


   

dasyscyphin E

dasyscyphin E

C22H32O2 (328.2402)


   

19-nor,14alphaH-cheilantha-13(24),16-diene

19-nor,14alphaH-cheilantha-13(24),16-diene

C24H40 (328.313)


   
   

ceratodictyol A

ceratodictyol A

C19H36O4 (328.2613)


   

3-heptadecadienylphenol

3-heptadecadienylphenol

C23H36O (328.2766)


   

4-oxooctyl-2-hydroxyundecanoate

4-oxooctyl-2-hydroxyundecanoate

C19H36O4 (328.2613)


   

14,18-dinor-plakortide Q

14,18-dinor-plakortide Q

C19H36O4 (328.2613)


   

ceratodictyol B

ceratodictyol B

C19H36O4 (328.2613)


   

Totarol acetate

Totarol acetate

C22H32O2 (328.2402)


   

docosa-4,8,12,15,18,21-hexaenoic acid|Docosa-4,8,12,15,18,21-hexaensaeure|Docosahexaensaeure aus Fischoelen

docosa-4,8,12,15,18,21-hexaenoic acid|Docosa-4,8,12,15,18,21-hexaensaeure|Docosahexaensaeure aus Fischoelen

C22H32O2 (328.2402)


   

5-pentadecatrienyl resorcinol-3-methyl ether

5-pentadecatrienyl resorcinol-3-methyl ether

C22H32O2 (328.2402)


   

1,4-dihydroxyheptadec-16-en-2-yl acetate

NCGC00385642-01!1,4-dihydroxyheptadec-16-en-2-yl acetate

C19H36O4 (328.2613)


   

1,2-dihydroxyheptadec-16-en-4-yl acetate

NCGC00385126-01!1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613)


   

2,4-dihydroxyheptadec-16-enyl acetate

NCGC00095546-02!2,4-dihydroxyheptadec-16-enyl acetate

C19H36O4 (328.2613)


   

DHA-[21,21,22,22,22-d5]

DHA-[21,21,22,22,22-d5]

C22H32O2 (328.2402)


Chemical was purchased from CAY 10005057 (Lot. 0462571-3); Diagnostic ions: 332.2, 288.4, 234.1,196.2, 182.2

   

Stanozolol

Stanozolol

C21H32N2O (328.2515)


A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   

Docosahexanoic acid

Docosahexanoic acid

C22H32O2 (328.2402)


   

1,2-dihydroxyheptadec-16-en-4-yl acetate

1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613)


   

2,4-Dihydroxyheptadec-16-enyl acetate

2,4-Dihydroxyheptadec-16-enyl acetate

C19H36O4 (328.2613)


   
   

5-methoxy aureol

5-methoxy aureol

C22H32O2 (328.2402)


   

DHA-[d5]

DHA-[d5]

C22H32O2 (328.2402)


NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ]; CONFIDENCE standard compound CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ]; CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0137.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001353.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]

   

2,4-dihydroxyheptadec-16-enyl acetate [IIN-based on: CCMSLIB00000848387]

NCGC00095546-02!2,4-dihydroxyheptadec-16-enyl acetate [IIN-based on: CCMSLIB00000848387]

C19H36O4 (328.2613)


   

2,4-dihydroxyheptadec-16-enyl acetate [IIN-based: Match]

NCGC00095546-02!2,4-dihydroxyheptadec-16-enyl acetate [IIN-based: Match]

C19H36O4 (328.2613)


   

1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based: Match]

NCGC00385642-01!1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based: Match]

C19H36O4 (328.2613)


   

1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based on: CCMSLIB00000845027]

NCGC00385642-01!1,4-dihydroxyheptadec-16-en-2-yl acetate [IIN-based on: CCMSLIB00000845027]

C19H36O4 (328.2613)


   

Docosahexaenoate

Docosahexaenoate

C22H32O2 (328.2402)


   

DOCOSAHEXAENOIC ACID

DOCOSAHEXAENOIC ACID

C22H32O2 (328.2402)


   

1,2-dihydroxyheptadec-16-en-4-yl acetate_major

1,2-dihydroxyheptadec-16-en-4-yl acetate_major

C19H36O4 (328.2613)


   

2,4-dihydroxyheptadec-16-enyl acetate_major

2,4-dihydroxyheptadec-16-enyl acetate_major

C19H36O4 (328.2613)


   

Totarol Acetate_major

Totarol Acetate_major

C22H32O2 (328.2402)


   

Totarol Acetate_66.0\\%

Totarol Acetate_66.0\\%

C22H32O2 (328.2402)


   

Totarol Acetate_63.9\\%

Totarol Acetate_63.9\\%

C22H32O2 (328.2402)


   

1,2-dihydroxyheptadec-16-en-4-yl acetate_64.3\\%

1,2-dihydroxyheptadec-16-en-4-yl acetate_64.3\\%

C19H36O4 (328.2613)


   

Totarol Acetate_58.1\\%

Totarol Acetate_58.1\\%

C22H32O2 (328.2402)


   

h_198_stanozolol

h_198_stanozolol

C21H32N2O (328.2515)


   

3a-OH-5aH-Degestrel

3a-OH-5aH-Degestrel

C22H32O2 (328.2402)


   

17-Epistanozolol

17-Epistanozolol

C21H32N2O (328.2515)


   

3R-hydroxy-eicosanoic acid

Eicosanoic acid, 3-hydroxy-, D-(-)-

C20H40O3 (328.2977)


   

15S-HETE-d8

15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid-d8

C20H24D8O3 (328.2853)


   

12S-HETE-d8

12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid-d8

C20H24D8O3 (328.2853)


   

(±)11,12-EpETrE-d8

11,12-epoxy-5Z,8Z,14Z-eicosatrienoic acid-d8

C20H24D8O3 (328.2853)


   

5S-HETE-d8

5S-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5,6,8,9,11,12,14,15-d8)

C20H24D8O3 (328.2853)


   

Retinyl acetate

Retinol Acetate/All-trans-retinyl Acetate

C22H32O2 (328.2402)


C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents D007155 - Immunologic Factors Retinyl acetate is a synthetic acetate ester form derived from retinol and has potential antineoplastic and chemo preventive activities.

   

avocadene acetate

2S,4S-dihydroxy-16E-heptadecen-1-yl-acetate

C19H36O4 (328.2613)


   

DHA (d5)

4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid (d5)

C22H32O2 (328.2402)


   

2-Hydroxyphytanic acid

2-hydroxy-3,7,11,15-tetramethylhexadecanoic acid

C20H40O3 (328.2977)


An alpha-hydroxy fatty acid formed from phytanic acid by bacterial cytochrome P450; and also formed in human peroxisomal disorders.

   

MG(16:1)

1-(9Z-hexadecenoyl)-rac-glycerol

C19H36O4 (328.2613)


   

DOCOSA-2,4,6,8,10,12-HEXAENOIC ACID

(4E,7E,10Z,13E,16E,19E)-Docosa-4,7,10,13,16,19-hexaenoic acid

C22H32O2 (328.2402)


   

3,9,15-Docosatriynoic acid

3,9,15-Docosatriynoic acid

C22H32O2 (328.2402)


   

8,11,14-Docosatriynoic acid

8,11,14-Docosatriynoic acid

C22H32O2 (328.2402)


   

10,13,16-Docosatriynoic acid

10,13,16-Docosatriynoic acid

C22H32O2 (328.2402)


   

2-hydroxy-eicosanoic acid

2-hydroxy-eicosanoic acid

C20H40O3 (328.2977)


   

3-hydroxy-eicosanoic acid

3-hydroxy-eicosanoic acid

C20H40O3 (328.2977)


   

20-hydroxy-eicosanoic acid

20-hydroxy-eicosanoic acid

C20H40O3 (328.2977)


   

Neogrifolin

5-methyl-4-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,3-diol

C22H32O2 (328.2402)


   

Grifolin

5-methyl-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,3-diol

C22H32O2 (328.2402)


   

Avocadene 2-acetate

1,4-dihydroxyheptadec-16-en-2-yl acetate

C19H36O4 (328.2613)


   

Avocadene 4-acetate

1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613)


   

Ivorit

17-Hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl octadecanoate

C20H40O3 (328.2977)


D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

   

(Z,Z)-2-Methyl-5-(8,11,14-pentadecatrienyl)-1,3-benzenediol

2-methyl-5-[(8Z,11E)-pentadeca-8,11,14-trien-1-yl]benzene-1,3-diol

C22H32O2 (328.2402)


   

20:1(9Z)(20F)

20-fluoro-9Z-eicosenoic acid

C20H37FO2 (328.2777)


   

20:1(11Z)(20F)

20-fluoro-11Z-eicosenoic acid

C20H37FO2 (328.2777)


   

FA 22:6

C22:6n-2,5,8,11,14,17;Docosahexaenoate;5Z,8Z,11Z,14Z,17Z,20Z-docosahexaenoate

C22H32O2 (328.2402)


   

FA 20:0;O

Eicosanoic acid, 3-hydroxy-, D-(-)-

C20H40O3 (328.2977)


   

FA 19:1;O2

Nonadecane-1,19-dioic acid

C19H36O4 (328.2613)


   

(+/-)14,15-EpETrE-(d8)

14,15-epoxy-5Z,8Z,11Z-eicosatrienoic acid-(d8)

C20H24D8O3 (328.2853)


   

(+/-)8,9-EpETrE-(d8)

8,9-epoxy-5Z,11Z,14Z-eicosatrienoic acid-(d8)

C20H24D8O3 (328.2853)


   

(+/-)11,12-EpETrE-d8

11,12-epoxy-5Z,8Z,14Z-eicosatrienoic acid-d8

C20H24D8O3 (328.2853)


   

FOH 19:2;O3

1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613)


   

N-lauroyl lysine

(S)-6-Amino-2-dodecanamidohexanoic acid

C18H36N2O3 (328.2726)


   

N6-lauroyl lysine

(2S)-2-amino-6-(dodecanoylamino) hexanoic acid

C18H36N2O3 (328.2726)


   

L-2-Hydroxyphytanate

(2S)-2-hydroxy-3,7,11,15-tetramethylhexadecanoic acid

C20H40O3 (328.2977)


   

2-methyl-5-(8Z.11,14-pentadecatrienyl) resorcinol

2-methyl-5-[(8Z,11Z)-pentadeca-8,11,14-trienyl]1,3-benzenediol

C22H32O2 (328.2402)


   

1-[3-(tert-Butoxycarbonyl-Methyl-amino)-propyl]-piperidine-4-carboxylic acid ethyl ester

1-[3-(tert-Butoxycarbonyl-Methyl-amino)-propyl]-piperidine-4-carboxylic acid ethyl ester

C17H32N2O4 (328.2362)


   

3-[[3-(dodecylamino)propyl]amino]butyric acid

3-[[3-(dodecylamino)propyl]amino]butyric acid

C19H40N2O2 (328.309)


   

12-hydroxystearic acid ethyl ester

12-hydroxystearic acid ethyl ester

C20H40O3 (328.2977)


   

20-(hydroxymethyl)pregna-1,4-dien-3-one

20-(hydroxymethyl)pregna-1,4-dien-3-one

C22H32O2 (328.2402)


   

Glyceryl palmitoleate

1-Palmitoleoyl glycerol

C19H36O4 (328.2613)


   

PPG-2 MYRISTYL ETHER PROPIONATE

PPG-2 MYRISTYL ETHER PROPIONATE

C20H40O3 (328.2977)


   

N2-Dodecanoyl-L-lysine

N2-Dodecanoyl-L-lysine

C18H36N2O3 (328.2726)


   

2-(3-aminophenyl)quinoline-4-carboxylic acid

2-(3-aminophenyl)quinoline-4-carboxylic acid

C19H36O4 (328.2613)


   

(2R)-2-[(8S,9S,10R,13S,14S,17R)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]propanal

(2R)-2-[(8S,9S,10R,13S,14S,17R)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]propanal

C22H32O2 (328.2402)


   

propylene di(octanoate)

propylene di(octanoate)

C19H36O4 (328.2613)


   

Nonadecanedioic acid

Nonadecanedioic acid

C19H36O4 (328.2613)


   

Dihexyl adipate

4,7,10,13,16,19-Docosahexaenoic acid

C22H32O2 (328.2402)


   

1,2-/1,4-dimethyladamantane

1,2-/1,4-dimethyladamantane

C24H40 (328.313)


   

1,9-Nonanediyl-bis(3-methylimidazolium) difluoride solution

1,9-Nonanediyl-bis(3-methylimidazolium) difluoride solution

C17H30F2N4 (328.2438)


   

N-[3-(dimethylamino)propyl]myristamide N-oxide

N-[3-(dimethylamino)propyl]myristamide N-oxide

C19H40N2O2 (328.309)


   

2-butyl-3,5-(and 3,6)-dimethyl pyrazine

2-butyl-3,5-(and 3,6)-dimethyl pyrazine

C20H32N4 (328.2627)


   

3-Oxopregn-4-ene-20-carbaldehyde

3-Oxopregn-4-ene-20-carbaldehyde

C22H32O2 (328.2402)


   

tert-Butyl (S)-4-(dimethylamino)-1-(piperazine-1-carbonyl)butylcarbamate

tert-Butyl (S)-4-(dimethylamino)-1-(piperazine-1-carbonyl)butylcarbamate

C16H32N4O3 (328.2474)


   

(+/-)-2-aminoheptane sulfate

(+/-)-2-aminoheptane sulfate

C14H36N2O4S (328.2396)


   

4,4-Dimethyl Retinoic Acid

4,4-Dimethyl Retinoic Acid

C22H32O2 (328.2402)


   

2-hexadecyl-malonic acid

2-hexadecyl-malonic acid

C19H36O4 (328.2613)


   

dioctyl malonate

dioctyl malonate

C19H36O4 (328.2613)


   

Zuretinol acetate

Zuretinol acetate

C22H32O2 (328.2402)


C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents D007155 - Immunologic Factors

   

Bisnorcholenaldehyde

Bisnorcholenaldehyde

C22H32O2 (328.2402)


   

C20 3-dehydrosphinganine(1+)

C20 3-dehydrosphinganine(1+)

C20H42NO2+ (328.3215)


   

N2-(1-Oxododecyl)-L-lysine

N2-(1-Oxododecyl)-L-lysine

C18H36N2O3 (328.2726)


   
   

Palmitic acid, 4-hydroxybutyl ester

Palmitic acid, 4-hydroxybutyl ester

C20H40O3 (328.2977)


   

Palmitoyllactic acid

Palmitoyllactic acid

C19H36O4 (328.2613)


   

Methyl 3-(acetyloxy)hexadecanoate

Methyl 3-(acetyloxy)hexadecanoate

C19H36O4 (328.2613)


   

Polyoxyethylene stearate

Ethylene glycol monostearate

C20H40O3 (328.2977)


D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

   

Docosahexaenoic Acid-d5

Docosahexaenoic Acid-d5

C22H32O2 (328.2402)


   

5-(Pentadeca-8,11,14-trien-1-yl)resorcinol monomethyl ether

5-(Pentadeca-8,11,14-trien-1-yl)resorcinol monomethyl ether

C22H32O2 (328.2402)


   

omega-Hydroxyphytanic acid

omega-Hydroxyphytanic acid

C20H40O3 (328.2977)


A hydroxy fatty acid obtained by hydroxylation of one of the two terminal methyl groups of phytanic acid.

   

2-Methyl-6-farnesyl-1,4-benzoquinol

2-Methyl-6-farnesyl-1,4-benzoquinol

C22H32O2 (328.2402)


   

N-(3-Hydroxyhexadecanoyl)glycine

N-(3-Hydroxyhexadecanoyl)glycine

C18H34NO4- (328.2488)


   

(2R,3S)-3-hydroxy-2-octyldodecanoic acid

(2R,3S)-3-hydroxy-2-octyldodecanoic acid

C20H40O3 (328.2977)


   

(4E,7E,10Z,13E,16E,19E)-Docosa-4,7,10,13,16,19-hexaenoic acid

(4E,7E,10Z,13E,16E,19E)-Docosa-4,7,10,13,16,19-hexaenoic acid

C22H32O2 (328.2402)


   

[3-carboxy-2-[(E)-undec-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-4-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2488)


   

9-Hexadecenoic acid 2,3-dihydroxypropyl ester

9-Hexadecenoic acid 2,3-dihydroxypropyl ester

C19H36O4 (328.2613)


   

(3-Carboxy-2-undec-10-enoyloxypropyl)-trimethylazanium

(3-Carboxy-2-undec-10-enoyloxypropyl)-trimethylazanium

C18H34NO4+ (328.2488)


   

[3-carboxy-2-[(E)-undec-6-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-6-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2488)


   

[3-carboxy-2-[(E)-undec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-2-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2488)


   

[3-carboxy-2-[(E)-undec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-5-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2488)


   

[3-carboxy-2-[(E)-undec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-7-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2488)


   

[3-carboxy-2-[(E)-undec-3-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-3-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2488)


   

[3-carboxy-2-[(E)-undec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-9-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2488)


   

[3-carboxy-2-[(E)-undec-8-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-undec-8-enoyl]oxypropyl]-trimethylazanium

C18H34NO4+ (328.2488)


   

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxotridec-4-enyl]-trimethylazanium

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxotridec-4-enyl]-trimethylazanium

C18H34NO4+ (328.2488)


   

CID 157010280

CID 157010280

C20H42NO2 (328.3215)


   

acetic acid [(4bS)-4b,8,8-trimethyl-1-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl] ester

acetic acid [(4bS)-4b,8,8-trimethyl-1-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl] ester

C22H32O2 (328.2402)


   

7alpha-Methyl-4-pregnene-3,20-dione

7alpha-Methyl-4-pregnene-3,20-dione

C22H32O2 (328.2402)


   

6alpha-Methylprogesterone

6alpha-Methylpregn-4-ene-3,20-dione

C22H32O2 (328.2402)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

19-Hydroxyicosanoic acid

19-Hydroxyicosanoic acid

C20H40O3 (328.2977)


   

N,N-dimethylsphingosine(1+)

N,N-dimethylsphingosine(1+)

C20H42NO2+ (328.3215)


A sphingoid base(1+) that is the conjugate acid of N,N-dimethylsphingosine, obtained by protonation of the primary amino group; major species at pH 7.3.

   

C20 sphingosine(1+)

C20 sphingosine(1+)

C20H42NO2+ (328.3215)


A cationic sphingoid that is the conjugate acid of C20 sphingosine, obtained by protonation of the primary amino function; major species at pH 7.3.

   

CID 6433873

CID 6433873

C22H32O2 (328.2402)


   

(19R)-19-hydroxyicosanoic acid

(19R)-19-hydroxyicosanoic acid

C20H40O3 (328.2977)


An (omega-1)-hydroxy fatty acid that is arachidic acid acid in which the 19-pro-R hydrogen is replaced by a hydroxy group.

   

(2S)-hydroxy(palmitoylamino)acetate

(2S)-hydroxy(palmitoylamino)acetate

C18H34NO4- (328.2488)


   

(1R,2S,10S,13R,14R,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

(1R,2S,10S,13R,14R,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

C21H32N2O (328.2515)


   

N-[(5S)-5-(hexanoylamino)-6-hydroxyhexyl]hexanamide

N-[(5S)-5-(hexanoylamino)-6-hydroxyhexyl]hexanamide

C18H36N2O3 (328.2726)


   

Hexadecanoic acid, trimethylsilyl ester

Hexadecanoic acid, trimethylsilyl ester

C19H40O2Si (328.2797)


   

O-Methylaureol

O-Methylaureol

C22H32O2 (328.2402)


   

Pimelic acid, di(hexyl) ester

Pimelic acid, di(hexyl) ester

C19H36O4 (328.2613)


   

6-[[[(1S)-1-(4-ethylphenyl)-2-methylpropyl]amino]methyl]-2-N,2-N-dimethyl-1,3,5-triazine-2,4-diamine

6-[[[(1S)-1-(4-ethylphenyl)-2-methylpropyl]amino]methyl]-2-N,2-N-dimethyl-1,3,5-triazine-2,4-diamine

C18H28N6 (328.2375)


   

Undecanedioic acid dibutyl ester

Undecanedioic acid dibutyl ester

C19H36O4 (328.2613)


   

2-Methylpentadecanoic acid trimethylsilyl ester

2-Methylpentadecanoic acid trimethylsilyl ester

C19H40O2Si (328.2797)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] acetate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] acetate

C19H36O4 (328.2613)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] propanoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] propanoate

C19H36O4 (328.2613)


   

[(2S)-2,3-dihydroxypropyl] (E)-hexadec-9-enoate

[(2S)-2,3-dihydroxypropyl] (E)-hexadec-9-enoate

C19H36O4 (328.2613)


   

Fahfa 11:0/8:0

Fahfa 11:0/8:0

C19H36O4 (328.2613)


   

Fahfa 13:0/6:0

Fahfa 13:0/6:0

C19H36O4 (328.2613)


   

Fahfa 6:0/13:0

Fahfa 6:0/13:0

C19H36O4 (328.2613)


   

Fahfa 14:0/5:0

Fahfa 14:0/5:0

C19H36O4 (328.2613)


   

Fahfa 10:0/9:0

Fahfa 10:0/9:0

C19H36O4 (328.2613)


   

Fahfa 5:0/14:0

Fahfa 5:0/14:0

C19H36O4 (328.2613)


   

Fahfa 2:0/17:0

Fahfa 2:0/17:0

C19H36O4 (328.2613)


   

Fahfa 7:0/12:0

Fahfa 7:0/12:0

C19H36O4 (328.2613)


   

Fahfa 15:0/4:0

Fahfa 15:0/4:0

C19H36O4 (328.2613)


   

Fahfa 12:0/7:0

Fahfa 12:0/7:0

C19H36O4 (328.2613)


   

Fahfa 9:0/10:0

Fahfa 9:0/10:0

C19H36O4 (328.2613)


   

Fahfa 3:0/16:0

Fahfa 3:0/16:0

C19H36O4 (328.2613)


   

Fahfa 8:0/11:0

Fahfa 8:0/11:0

C19H36O4 (328.2613)


   

Fahfa 4:0/15:0

Fahfa 4:0/15:0

C19H36O4 (328.2613)


   

Isopalmitic acid trimethylsilyl

Isopalmitic acid trimethylsilyl

C19H40O2Si (328.2797)


   

2-Heptadecanoyloxyacetic acid

2-Heptadecanoyloxyacetic acid

C19H36O4 (328.2613)


   

(1S,2S,10S,13R,14S,17S,18R)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

(1S,2S,10S,13R,14S,17S,18R)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

C21H32N2O (328.2515)


   

[(2S)-2,3-dihydroxypropyl] (E)-hexadec-7-enoate

[(2S)-2,3-dihydroxypropyl] (E)-hexadec-7-enoate

C19H36O4 (328.2613)


   

Doconexent

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid

C22H32O2 (328.2402)


A docosahexaenoic acid having six cis-double bonds at positions 4, 7, 10, 13, 16 and 19. COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.

   

(2S)-2-hydroxyphytanic acid

(2S)-2-hydroxyphytanic acid

C20H40O3 (328.2977)


A 20-carbon, methyl-branched hydroxy fatty acid and intermediate in phytanic acid degradation; accumulates in patients with peroxisimal disorders.

   

Avocadene 1-acetate

Avocadene 1-acetate

C19H36O4 (328.2613)


   

2-[(9Z)-hexadecenoyl]glycerol

2-[(9Z)-hexadecenoyl]glycerol

C19H36O4 (328.2613)


A monoacylglycerol 16:1 in which the acyl group specified at position 2 is 9Z)-hexadecenoyl.

   

2-hydroxyarachidic acid

2-hydroxyarachidic acid

C20H40O3 (328.2977)


A long-chain fatty acid that is arachidic (icosanoic) acid substituted at position 2 by a hydroxy group.

   

3-hydroxyicosanoic acid

3-hydroxyicosanoic acid

C20H40O3 (328.2977)


A long-chain fatty acid that is icosanoic acid carrying a 3-hydroxy substituent.

   

15-hydroxyicosanoic acid

15-hydroxyicosanoic acid

C20H40O3 (328.2977)


   

12-hydroxyicosanoic acid

12-hydroxyicosanoic acid

C20H40O3 (328.2977)


   
   

11-methoxynonadecanoic acid

11-methoxynonadecanoic acid

C20H40O3 (328.2977)


   

20-fluoro-9Z-eicosenoic acid

20-fluoro-9Z-eicosenoic acid

C20H37FO2 (328.2777)


   

monoacylglycerol 16:1

monoacylglycerol 16:1

C19H36O4 (328.2613)


A monoglyceride in which the acyl group contains a total of 16 carbon atoms and 1 double bond.

   

2-acylglycerol 16:1

2-acylglycerol 16:1

C19H36O4 (328.2613)


A 2-monoglyceride in which the acyl group contains 16 carbons and 1 double bond.

   

DG(16:1)

DG(10:1(1)_6:0)

C19H36O4 (328.2613)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

Hydroxyeicosanoic acid

Hydroxyeicosanoic acid

C20H40O3 (328.2977)


   

Docosatriynoic acid

Docosatriynoic acid

C22H32O2 (328.2402)


   
   
   
   
   
   

NA-Tryptamine 11:0

NA-Tryptamine 11:0

C21H32N2O (328.2515)


   

FAHFA 10:0/3O-9:0

FAHFA 10:0/3O-9:0

C19H36O4 (328.2613)


   

FAHFA 10:0/O-9:0

FAHFA 10:0/O-9:0

C19H36O4 (328.2613)


   

FAHFA 11:0/3O-8:0

FAHFA 11:0/3O-8:0

C19H36O4 (328.2613)


   

FAHFA 11:0/O-8:0

FAHFA 11:0/O-8:0

C19H36O4 (328.2613)


   

FAHFA 13:0/3O-6:0

FAHFA 13:0/3O-6:0

C19H36O4 (328.2613)


   

FAHFA 19:0;O

FAHFA 19:0;O

C19H36O4 (328.2613)


   

FAHFA 4:0/15O-15:0

FAHFA 4:0/15O-15:0

C19H36O4 (328.2613)


   

FAHFA 5:0/2O-14:0

FAHFA 5:0/2O-14:0

C19H36O4 (328.2613)


   

FAHFA 6:0/3O-13:0

FAHFA 6:0/3O-13:0

C19H36O4 (328.2613)


   

FAHFA 7:0/3O-12:0

FAHFA 7:0/3O-12:0

C19H36O4 (328.2613)


   

FAHFA 8:0/3O-11:0

FAHFA 8:0/3O-11:0

C19H36O4 (328.2613)


   

FAHFA 8:0/O-11:0

FAHFA 8:0/O-11:0

C19H36O4 (328.2613)


   

FAHFA 9:0/3O-10:0

FAHFA 9:0/3O-10:0

C19H36O4 (328.2613)


   

FAHFA 9:0/O-10:0

FAHFA 9:0/O-10:0

C19H36O4 (328.2613)


   

MG 0:0/16:1(9Z)/0:0

MG 0:0/16:1(9Z)/0:0

C19H36O4 (328.2613)


   
   

MG 16:1(9Z)/0:0/0:0

MG 16:1(9Z)/0:0/0:0

C19H36O4 (328.2613)


   

Hydroxyphytanic acid

Hydroxyphytanic acid

C20H40O3 (328.2977)


   
   

ST 23:2;O

ST 23:2;O

C23H36O (328.2766)


   

(2r,4r)-2,4-dihydroxyheptadec-16-en-1-yl acetate

(2r,4r)-2,4-dihydroxyheptadec-16-en-1-yl acetate

C19H36O4 (328.2613)


   

[(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methyl acetate

[(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methyl acetate

C22H32O2 (328.2402)


   

(4e)-1-[(2s)-2,3-dihydroxypropoxy]hexadec-4-en-6-one

(4e)-1-[(2s)-2,3-dihydroxypropoxy]hexadec-4-en-6-one

C19H36O4 (328.2613)


   

2-(4,8-dimethylnona-3,7-dien-1-yl)-2,8-dimethyl-3,4-dihydro-1-benzopyran-6-ol

2-(4,8-dimethylnona-3,7-dien-1-yl)-2,8-dimethyl-3,4-dihydro-1-benzopyran-6-ol

C22H32O2 (328.2402)


   

(2s,4as,10as)-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-2-yl acetate

(2s,4as,10as)-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-2-yl acetate

C22H32O2 (328.2402)


   

(2r)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2,7-dimethyl-3,4-dihydro-1-benzopyran-6-ol

(2r)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2,7-dimethyl-3,4-dihydro-1-benzopyran-6-ol

C22H32O2 (328.2402)


   

3-methoxy-2-[(1r,6r)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-5-pentylphenol

3-methoxy-2-[(1r,6r)-3-methyl-6-(prop-1-en-2-yl)cyclohex-2-en-1-yl]-5-pentylphenol

C22H32O2 (328.2402)


   

docosa-5,8,11,14,17,20-hexaenoic acid

docosa-5,8,11,14,17,20-hexaenoic acid

C22H32O2 (328.2402)


   

6-isopropyl-4,5-dimethoxy-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7-tetraene

6-isopropyl-4,5-dimethoxy-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7-tetraene

C22H32O2 (328.2402)


   

(5e,8e,11e,14e,17e,20e)-docosa-5,8,11,14,17,20-hexaenoic acid

(5e,8e,11e,14e,17e,20e)-docosa-5,8,11,14,17,20-hexaenoic acid

C22H32O2 (328.2402)


   

(4s,4ar,6as,11ar,11br)-4-(hydroxymethyl)-4,6a,8,11b-tetramethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluoren-7-ol

(4s,4ar,6as,11ar,11br)-4-(hydroxymethyl)-4,6a,8,11b-tetramethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluoren-7-ol

C22H32O2 (328.2402)


   

2-[(3r,6e,10z)-6,10-dimethylbicyclo[12.1.0]pentadeca-1,6,10,14-tetraen-3-yl]propan-2-yl acetate

2-[(3r,6e,10z)-6,10-dimethylbicyclo[12.1.0]pentadeca-1,6,10,14-tetraen-3-yl]propan-2-yl acetate

C22H32O2 (328.2402)


   

2,4-dimethyl-6-(3'-m ethyl-isobuten-5'-iso-propyl)-phenyl-3,5-hexanedione

NA

C22H32O2 (328.2402)


{"Ingredient_id": "HBIN004352","Ingredient_name": "2,4-dimethyl-6-(3'-m ethyl-isobuten-5'-iso-propyl)-phenyl-3,5-hexanedione","Alias": "NA","Ingredient_formula": "C22H32O2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6374","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2z-phytene-1,15,20-triol

NA

C20H40O3 (328.2977)


{"Ingredient_id": "HBIN006868","Ingredient_name": "2z-phytene-1,15,20-triol","Alias": "NA","Ingredient_formula": "C20H40O3","Ingredient_Smile": "CC(CCCC(C)CCCC(C)(C)O)CCCC(=CCO)CO","Ingredient_weight": "328.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "17241","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12080816","DrugBank_id": "NA"}

   

3-epicaonamine

NA

C22H36N2 (328.2878)


{"Ingredient_id": "HBIN008471","Ingredient_name": "3-epicaonamine","Alias": "NA","Ingredient_formula": "C22H36N2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25801","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-epiconamine

NA

C22H36N2 (328.2878)


{"Ingredient_id": "HBIN008472","Ingredient_name": "3-epiconamine","Alias": "NA","Ingredient_formula": "C22H36N2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6872","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

9,12-dihydroxy-15-nonadecenoic acid

9,12-dihydroxy-15-nonadecenoicacid

C19H36O4 (328.2613)


{"Ingredient_id": "HBIN013990","Ingredient_name": "9,12-dihydroxy-15-nonadecenoic acid","Alias": "9,12-dihydroxy-15-nonadecenoicacid","Ingredient_formula": "C19H36O4","Ingredient_Smile": "CCCC=CCCC(CCC(CCCCCCCC(=O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25887;6046","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-[(1-hydroxy-11-methyldodecylidene)amino]-3-(c-hydroxycarbonimidoyl)propanoic acid

2-[(1-hydroxy-11-methyldodecylidene)amino]-3-(c-hydroxycarbonimidoyl)propanoic acid

C17H32N2O4 (328.2362)


   

3-[(15-methylhexadec-1-en-1-yl)oxy]propane-1,2-diol

3-[(15-methylhexadec-1-en-1-yl)oxy]propane-1,2-diol

C20H40O3 (328.2977)


   

(1s,2s,3r,6r,10s,11s,12s)-2-octyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,7-diene-7-carboxylic acid

(1s,2s,3r,6r,10s,11s,12s)-2-octyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,7-diene-7-carboxylic acid

C22H32O2 (328.2402)


   

(2s)-6-amino-2-[(1-hydroxydodecylidene)amino]hexanoic acid

(2s)-6-amino-2-[(1-hydroxydodecylidene)amino]hexanoic acid

C18H36N2O3 (328.2726)


   

5-methyl-4-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol

5-methyl-4-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol

C22H32O2 (328.2402)


   

4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-methyl-2-(3-methylbut-2-en-1-yl)benzene-1,3-diol

4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-methyl-2-(3-methylbut-2-en-1-yl)benzene-1,3-diol

C22H32O2 (328.2402)


   

(1s,2s,3r,6r,7r,10s,11s,12s)-2-octyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylic acid

(1s,2s,3r,6r,7r,10s,11s,12s)-2-octyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylic acid

C22H32O2 (328.2402)


   

2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl acetate

2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl acetate

C22H32O2 (328.2402)


   

(5ar,7as,11ar,11bs)-2-methoxy-5a,9,9,11a-tetramethyl-6,7,7a,8,10,11,11b,12-octahydro-5-oxatetraphene

(5ar,7as,11ar,11bs)-2-methoxy-5a,9,9,11a-tetramethyl-6,7,7a,8,10,11,11b,12-octahydro-5-oxatetraphene

C22H32O2 (328.2402)


   

2-methyl-5-[(2z,6z)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,4-diol

2-methyl-5-[(2z,6z)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,4-diol

C22H32O2 (328.2402)


   

undecyl 4-hydroxynonanoate

undecyl 4-hydroxynonanoate

C20H40O3 (328.2977)


   

(1r,10r,13s,16s,17z)-16-isopropyl-1,13-dimethyl-2-oxatricyclo[8.8.0.0³,⁸]octadeca-3,5,7,17-tetraen-13-ol

(1r,10r,13s,16s,17z)-16-isopropyl-1,13-dimethyl-2-oxatricyclo[8.8.0.0³,⁸]octadeca-3,5,7,17-tetraen-13-ol

C22H32O2 (328.2402)


   

6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

C22H36N2 (328.2878)


   

1-{3a,11a-dimethyl-1h,2h,3h,4h,5h,5ah,6h,11bh-cyclopenta[c]xanthen-1-yl}-2-methylpropan-1-ol

1-{3a,11a-dimethyl-1h,2h,3h,4h,5h,5ah,6h,11bh-cyclopenta[c]xanthen-1-yl}-2-methylpropan-1-ol

C22H32O2 (328.2402)


   

(2e,7r,11s,12s,14r)-3,7,11,15-tetramethylhexadec-2-ene-1,12,14-triol

(2e,7r,11s,12s,14r)-3,7,11,15-tetramethylhexadec-2-ene-1,12,14-triol

C20H40O3 (328.2977)


   

(4bs,8as)-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl acetate

(4bs,8as)-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl acetate

C22H32O2 (328.2402)


   

4-(hydroxymethyl)-4,6a,8,11b-tetramethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluoren-7-ol

4-(hydroxymethyl)-4,6a,8,11b-tetramethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluoren-7-ol

C22H32O2 (328.2402)


   

(2s,4s)-2,4-dihydroxyheptadec-16-en-1-yl acetate

(2s,4s)-2,4-dihydroxyheptadec-16-en-1-yl acetate

C19H36O4 (328.2613)


   

1-{4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl}ethanone

1-{4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl}ethanone

C23H36O (328.2766)


   

(11s)-6-isopropyl-4,5-dimethoxy-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7-tetraene

(11s)-6-isopropyl-4,5-dimethoxy-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7-tetraene

C22H32O2 (328.2402)


   

2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2,8-dimethyl-3,4-dihydro-1-benzopyran-6-ol

2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2,8-dimethyl-3,4-dihydro-1-benzopyran-6-ol

C22H32O2 (328.2402)


   

(4bs)-1-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl acetate

(4bs)-1-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl acetate

C22H32O2 (328.2402)


   

(2r)-2,3-dihydroxypropyl (9z)-hexadec-9-enoate

(2r)-2,3-dihydroxypropyl (9z)-hexadec-9-enoate

C19H36O4 (328.2613)


   

(7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl)methyl acetate

(7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl)methyl acetate

C22H32O2 (328.2402)


   

(1r)-1-[(1r,3as,5ar,11as,11bs)-3a,11a-dimethyl-1h,2h,3h,4h,5h,5ah,6h,11bh-cyclopenta[c]xanthen-1-yl]-2-methylpropan-1-ol

(1r)-1-[(1r,3as,5ar,11as,11bs)-3a,11a-dimethyl-1h,2h,3h,4h,5h,5ah,6h,11bh-cyclopenta[c]xanthen-1-yl]-2-methylpropan-1-ol

C22H32O2 (328.2402)


   

4-(3,7-dimethylocta-2,6-dien-1-yl)-5-methyl-2-(3-methylbut-2-en-1-yl)benzene-1,3-diol

4-(3,7-dimethylocta-2,6-dien-1-yl)-5-methyl-2-(3-methylbut-2-en-1-yl)benzene-1,3-diol

C22H32O2 (328.2402)


   

(2s)-3-{[(1z)-15-methylhexadec-1-en-1-yl]oxy}propane-1,2-diol

(2s)-3-{[(1z)-15-methylhexadec-1-en-1-yl]oxy}propane-1,2-diol

C20H40O3 (328.2977)


   

2-methyl-5-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,4-diol

2-methyl-5-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,4-diol

C22H32O2 (328.2402)


   

(2s)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2,8-dimethyl-3,4-dihydro-1-benzopyran-6-ol

(2s)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2,8-dimethyl-3,4-dihydro-1-benzopyran-6-ol

C22H32O2 (328.2402)


   

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-methyl-4-(3-methylbut-2-en-1-yl)benzene-1,3-diol

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-methyl-4-(3-methylbut-2-en-1-yl)benzene-1,3-diol

C22H32O2 (328.2402)


   

2-(3,7-dimethylocta-2,6-dien-1-yl)-5-methyl-4-(3-methylbut-2-en-1-yl)benzene-1,3-diol

2-(3,7-dimethylocta-2,6-dien-1-yl)-5-methyl-4-(3-methylbut-2-en-1-yl)benzene-1,3-diol

C22H32O2 (328.2402)


   

1-(2,3-dihydroxypropoxy)hexadec-4-en-6-one

1-(2,3-dihydroxypropoxy)hexadec-4-en-6-one

C19H36O4 (328.2613)


   

2-methoxy-5a,9,9,11a-tetramethyl-6,7,7a,8,10,11,11b,12-octahydro-5-oxatetraphene

2-methoxy-5a,9,9,11a-tetramethyl-6,7,7a,8,10,11,11b,12-octahydro-5-oxatetraphene

C22H32O2 (328.2402)


   

(2r)-2,3-dihydroxypropyl hexadec-9-enoate

(2r)-2,3-dihydroxypropyl hexadec-9-enoate

C19H36O4 (328.2613)


   

(6e)-1-[(2s)-2,3-dihydroxypropoxy]hexadec-6-en-5-one

(6e)-1-[(2s)-2,3-dihydroxypropoxy]hexadec-6-en-5-one

C19H36O4 (328.2613)


   

methyl 2-[(3r,4s,6s)-4,6-diethyl-6-[(2s)-2-ethylhexyl]-1,2-dioxan-3-yl]acetate

methyl 2-[(3r,4s,6s)-4,6-diethyl-6-[(2s)-2-ethylhexyl]-1,2-dioxan-3-yl]acetate

C19H36O4 (328.2613)


   

(5e,7r,9e,13e)-2,6,10-trimethyl-7-[(3r)-3-methylpent-4-en-1-yl]pentadeca-2,5,9,13-tetraene

(5e,7r,9e,13e)-2,6,10-trimethyl-7-[(3r)-3-methylpent-4-en-1-yl]pentadeca-2,5,9,13-tetraene

C24H40 (328.313)


   

2-methyl-5-(pentadeca-8,11,14-trien-1-yl)benzene-1,3-diol

2-methyl-5-(pentadeca-8,11,14-trien-1-yl)benzene-1,3-diol

C22H32O2 (328.2402)


   

7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-2-yl acetate

7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-2-yl acetate

C22H32O2 (328.2402)


   

1-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl acetate

1-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl acetate

C22H32O2 (328.2402)


   

2-methyl-5-[(8z,11z)-pentadeca-8,11,14-trien-1-yl]benzene-1,3-diol

2-methyl-5-[(8z,11z)-pentadeca-8,11,14-trien-1-yl]benzene-1,3-diol

C22H32O2 (328.2402)


   

(3s,4ar,6as,11ar,11br)-4,4,6a,8,11b-pentamethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluorene-3,7-diol

(3s,4ar,6as,11ar,11br)-4,4,6a,8,11b-pentamethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluorene-3,7-diol

C22H32O2 (328.2402)


   

undecyl (4r)-4-hydroxynonanoate

undecyl (4r)-4-hydroxynonanoate

C20H40O3 (328.2977)


   

5-methyl-2-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol

5-methyl-2-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol

C22H32O2 (328.2402)


   

2-methyl-6-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,4-diol

2-methyl-6-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,4-diol

C22H32O2 (328.2402)


   

methyl 2-[(3s,4s,6s)-4,6-diethyl-6-[(2s)-2-ethylhexyl]-1,2-dioxan-3-yl]acetate

methyl 2-[(3s,4s,6s)-4,6-diethyl-6-[(2s)-2-ethylhexyl]-1,2-dioxan-3-yl]acetate

C19H36O4 (328.2613)


   

1-(2,3-dihydroxypropoxy)hexadec-6-en-5-one

1-(2,3-dihydroxypropoxy)hexadec-6-en-5-one

C19H36O4 (328.2613)


   

3-(heptadeca-1,3-dien-1-yl)phenol

3-(heptadeca-1,3-dien-1-yl)phenol

C23H36O (328.2766)


   

5-methyl-2-[(6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,3-diol

5-methyl-2-[(6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,3-diol

C22H32O2 (328.2402)


   

1-[(1s,2s,3s,4r,5s,7s,8r)-4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl]ethanone

1-[(1s,2s,3s,4r,5s,7s,8r)-4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl]ethanone

C23H36O (328.2766)


   

1-[(1s,2s,3s,4r,5s,7s,8r,9r)-4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl]ethanone

1-[(1s,2s,3s,4r,5s,7s,8r,9r)-4-decyltetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-en-8-yl]ethanone

C23H36O (328.2766)


   

(2s)-2-amino-6-[(1-hydroxydodecylidene)amino]hexanoic acid

(2s)-2-amino-6-[(1-hydroxydodecylidene)amino]hexanoic acid

C18H36N2O3 (328.2726)


   

2-(4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl)propan-2-yl acetate

2-(4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl)propan-2-yl acetate

C22H32O2 (328.2402)


   

2-methyl-5-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,4-diol

2-methyl-5-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,4-diol

C22H32O2 (328.2402)


   

3,7,11,15-tetramethylhexadec-2-ene-1,12,14-triol

3,7,11,15-tetramethylhexadec-2-ene-1,12,14-triol

C20H40O3 (328.2977)


   

(1s,2r,5s,6r,9r,12s,13s,16r)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

(1s,2r,5s,6r,9r,12s,13s,16r)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-16-amine

C22H36N2 (328.2878)


   

4-oxooctyl (2r)-2-hydroxyundecanoate

4-oxooctyl (2r)-2-hydroxyundecanoate

C19H36O4 (328.2613)


   

(2r,4r)-1,2-dihydroxyheptadec-16-en-4-yl acetate

(2r,4r)-1,2-dihydroxyheptadec-16-en-4-yl acetate

C19H36O4 (328.2613)


   

2,6,10-trimethyl-7-(3-methylpent-4-en-1-yl)pentadeca-2,5,9,13-tetraene

2,6,10-trimethyl-7-(3-methylpent-4-en-1-yl)pentadeca-2,5,9,13-tetraene

C24H40 (328.313)


   

2-(4,8-dimethylnona-3,7-dien-1-yl)-2,7-dimethyl-3,4-dihydro-1-benzopyran-6-ol

2-(4,8-dimethylnona-3,7-dien-1-yl)-2,7-dimethyl-3,4-dihydro-1-benzopyran-6-ol

C22H32O2 (328.2402)


   

(4bs,8as)-1-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl acetate

(4bs,8as)-1-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl acetate

C22H32O2 (328.2402)


   

4,4,6a,8,11b-pentamethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluorene-3,7-diol

4,4,6a,8,11b-pentamethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluorene-3,7-diol

C22H32O2 (328.2402)


   

(1s,10r,13s,16s,17e)-16-isopropyl-1,13-dimethyl-2-oxatricyclo[8.8.0.0³,⁸]octadeca-3,5,7,17-tetraen-13-ol

(1s,10r,13s,16s,17e)-16-isopropyl-1,13-dimethyl-2-oxatricyclo[8.8.0.0³,⁸]octadeca-3,5,7,17-tetraen-13-ol

C22H32O2 (328.2402)


   

4-oxooctyl 2-hydroxyundecanoate

4-oxooctyl 2-hydroxyundecanoate

C19H36O4 (328.2613)


   

2-[(4bs,8as)-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl]propan-2-yl acetate

2-[(4bs,8as)-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-2-yl]propan-2-yl acetate

C22H32O2 (328.2402)